Capital Impact Advisors, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,441,000
-38.0%
72,794
-38.4%
0.99%
+7.9%
Q3 2021$2,324,000
-10.5%
118,0840.0%0.92%
+9.9%
Q2 2021$2,598,000
-35.0%
118,084
-29.7%
0.84%
-40.1%
Q1 2021$3,999,000
-13.8%
168,084
-5.2%
1.40%
+22.9%
Q4 2020$4,638,000
+50.3%
177,3000.0%1.14%
+24.5%
Q3 2020$3,086,000
+3.5%
177,3000.0%0.92%
-8.1%
Q2 2020$2,982,000
+41.5%
177,3000.0%1.00%
+12.5%
Q1 2020$2,108,000
+2.5%
177,300
+4.3%
0.88%
+22.2%
Q4 2019$2,057,000
-13.2%
169,988
+4.6%
0.72%
-19.8%
Q3 2019$2,370,000
+15.9%
162,544
-11.4%
0.90%
+20.6%
Q2 2019$2,044,000
-19.0%
183,470
-5.3%
0.75%
-32.9%
Q1 2019$2,522,0000.0%193,6940.0%1.12%
+3.7%
Q4 2018$2,522,000
+20.0%
193,694
+26.6%
1.08%
+49.4%
Q3 2018$2,101,000
+13.3%
152,989
+30.3%
0.72%
+5.1%
Q2 2018$1,854,000
+51.7%
117,439
+58.1%
0.69%
+36.7%
Q1 2018$1,222,000
-13.5%
74,298
-5.0%
0.50%
-17.7%
Q4 2017$1,412,000
-6.4%
78,1940.0%0.61%
-9.5%
Q3 2017$1,509,000
+63.5%
78,1940.0%0.67%
+60.5%
Q2 2017$923,000
-22.1%
78,194
-27.7%
0.42%
-11.0%
Q1 2017$1,185,000
+562.0%
108,150
+81.0%
0.47%
+461.9%
Q4 2014$179,000
+11.9%
59,7350.0%0.08%
Q3 2014$160,000
-4.2%
59,7350.0%0.00%
-100.0%
Q2 2014$167,00059,7350.13%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders